Overview
Hypothyroidism Research Study:
Investigating the efficacy and safety of Desiccated Thyroid Extract (DTE) Tablets for the Treatment of Primary Hypothyroidism
Hypothyroidism occurs when the thyroid gland does not produce enough hormones, which can affect energy levels, metabolism, and overall health. Many people with hypothyroidism take levothyroxine (LT4), a common thyroid hormone replacement medication.
Researchers are studying a new thyroid medication made from desiccated porcine (pig-derived) thyroid extract to see how well it works for people with primary hypothyroidism.
In this study, participants will take one tablet each day. They will receive either the study medication or levothyroxine, a standard treatment already used for hypothyroidism. This study does not use a placebo.
The goal of the study is to learn whether the investigational thyroid medication works as well as the standard levothyroxine treatment in managing hypothyroidism symptoms and thyroid hormone levels.
About the Study
A Randomized, Double-Blind, Noninferiority Study to Investigate the Efficacy and Safety of Desiccated Porcine Thyroid Extract Tablets for the Treatment of Primary Hypothyroidism.
Hypothyroidism Research Study:
This study is designed to confirm the utility of the investigational product, to treat hypothyroidism. The study is designed to evaluate safety and efficacy of DTE tablets as compared to synthetic T4 (Synthroid).
Who Can Join
Hypothyroidism Research Study Inclusion Criteria
You may be able to participate if you meet the following conditions:
- Ages 18 to 70 years.
-
Diagnosis of primary hypothyroidism.
-
Euthyroid status for at least 6 weeks and up to 12 months prior to Screening, with at least one documented minimum stable dose of 50 mcg LT4.
-
TSH value within the normal reference range per central laboratory.
- Weigh between 110 and 286 pounds
- Are currently taking a stable dose of levothyroxine or a similar thyroid medication for at least 12 weeks
- Take a daily thyroid medication dose of at least 50 mcg
- Have controlled blood pressure and diabetes, if applicable
-
Willing to use oral contraceptives or a barrier method of contraception if of childbearing potential.
You may not be eligible if you:
- Have a history of thyroid cancer
- Have taken certain medications that affect thyroid hormone levels or thyroid treatment
- Have taken weight-loss medications within the past 6 weeks
*Other conditions may apply
Not sure if you qualify?
A member of our study team will review your medical history and medications with you to determine if this study may be a good fit.
What to Expect
Study Duration:
Duration of participation is approximately 34 weeks, which includes a 4-week screening period, a 4-week run-in period, and a 24-week treatment period.
Study Visits:
Up to 8 visits over 34 weeks
Participants will return to the clinic at Week 6, Week 12, Week 18, and Week 24 for safety visits and end-of-study procedures.
Compensation:
You may be compensated for your time and travel related to study participation. To be discussed.